234 related articles for article (PubMed ID: 37724781)
1. Retraction.
Cancer Med; 2023 Sep; 12(18):19352. PubMed ID: 37724781
[TBL] [Abstract][Full Text] [Related]
2. Retraction.
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38108614
[TBL] [Abstract][Full Text] [Related]
3. Retraction.
Cancer Med; 2023 May; 12(9):11041. PubMed ID: 37050853
[TBL] [Abstract][Full Text] [Related]
4. Retracted: 14-3-3ζ promotes gliomas cells invasion by regulating Snail through the PI3K/AKT signaling.
Cancer Med; 2023 Jul; 12(14):15761. PubMed ID: 37439554
[TBL] [Abstract][Full Text] [Related]
5. Retraction.
Cancer Med; 2023 May; 12(9):11040. PubMed ID: 37046403
[TBL] [Abstract][Full Text] [Related]
6. Retraction.
Cancer Med; 2023 Dec; 12(24):22437. PubMed ID: 38100296
[TBL] [Abstract][Full Text] [Related]
7. Retraction.
Cancer Med; 2023 May; 12(10):12034. PubMed ID: 37097252
[TBL] [Abstract][Full Text] [Related]
8. Retraction: LINC01133 promotes the progression of cervical cancer via regulating miR-30a-5p/FOXD1.
Asia Pac J Clin Oncol; 2023 Dec; 19(6):762. PubMed ID: 37888963
[TBL] [Abstract][Full Text] [Related]
9. Withdrawal Notice.
Cancer Med; 2023 Sep; 12(18):19353. PubMed ID: 36372952
[TBL] [Abstract][Full Text] [Related]
10. Retraction.
J Cell Biochem; 2021 Nov; 122 Suppl 1():S90. PubMed ID: 34191358
[TBL] [Abstract][Full Text] [Related]
11. Retraction Statement.
Int J Clin Pract; 2021 Dec; 75(12):e14925. PubMed ID: 34636464
[TBL] [Abstract][Full Text] [Related]
12. RETRACTION: Long noncoding RNA UCA1 promotes cell growth, migration, and invasion by targeting miR-143-3p in oral squamous cell carcinoma.
Cancer Med; 2024 Jun; 13(11):e7338. PubMed ID: 38813651
[TBL] [Abstract][Full Text] [Related]
13. Retraction.
Br J Pharmacol; 2020 Jul; 177(13):3123. PubMed ID: 32512636
[TBL] [Abstract][Full Text] [Related]
14. Retraction.
J Cell Biochem; 2021 Nov; 122 Suppl 1():S89. PubMed ID: 34191342
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Chen, Y, Zhang, W, Kadier, A, Zhang, H, Yao, X. MicroRNA-769-5p suppresses cell growth and migration via targeting NUSAP1 in bladder cancer. J Clin Lab Anal. 2020; 34:e23193.
J Clin Lab Anal; 2023 Apr; 37(8):e24893. PubMed ID: 37183304
[TBL] [Abstract][Full Text] [Related]
16. Retraction Statement: CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.
J Neurochem; 2017 May; 141(3):473-474. PubMed ID: 28417467
[TBL] [Abstract][Full Text] [Related]
17. Retraction Statement.
Int J Clin Pract; 2021 Dec; 75(12):e14927. PubMed ID: 34636466
[TBL] [Abstract][Full Text] [Related]
18. Retraction.
Cancer Sci; 2023 Jul; 114(7):3057. PubMed ID: 37211924
[TBL] [Abstract][Full Text] [Related]
19. Retraction.
J Cell Biochem; 2021 Nov; 122 Suppl 1():S27. PubMed ID: 34107101
[TBL] [Abstract][Full Text] [Related]
20. Retraction.
J Cell Biochem; 2021 Nov; 122 Suppl 1():S85. PubMed ID: 34191319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
